Medications

Five years of legal cannabis in Canada: Mixed success

Five years after cannabis legalization in Canada, it appears to be a mixed success, with social justice benefits outweighing health benefits, write authors in a commentary published in CMAJ (Canadian Medical Association Journal).

Gastroenterology

Anti-inflammatory nanoparticles mimic glycocalyx in IBD patients

Cases of chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are on the rise worldwide. The benefits of current medications to treat patients with these diseases are limited by problematic ...

page 2 from 10